Reduced-Intensity Chemotherapy with Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study

Background: Inotuzumab ozogamicin (INO) and blinatumomab both improve overall survival (OS) in relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Use of these effective monoclonal antibodies in the frontline setting may lead to deep and durable remissions in older adults with newly di...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2020-11, Vol.136 (Supplement 1), p.15-17
Hauptverfasser:	Short, Nicholas J., Kantarjian, Hagop M., Ravandi, Farhad, Huang, Xuelin, Jain, Nitin, Kadia, Tapan M., Khoury, Joseph D., Jorgensen, Jeffrey L., Wang, Sa A, Alvarado, Yesid, Burger, Jan A., Daver, Naval, Borthakur, Gautam, DiNardo, Courtney D., Konopleva, Marina, Pemmaraju, Naveen, Garcia-Manero, Guillermo, Wierda, William G., Kornblau, Steven M., Jacob, Jovitta, Rostykus, Meagan, Kwari, Monica, Rausch, Caitlin R., Loiselle, Christopher, Milton, Anna, Rivera, Juan, Garris, Rebecca, O'Brien, Susan M., Jabbour, Elias
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!